Stem cell therapy in COVID-19

Phase 1

Recruiting

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20200418047121N2
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

Patients with COVID19
Acute respiratory infectious symptoms and severe lung involvement

Exclusion Criteria

Patients with mild symptoms and mild lung involvement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biomarker expression. Timepoint: two weeks after last cell therapy. Method of measurement: Flowcytometery.;IL-6 and IL-1 Level. Timepoint: Before Cell injection and two weeks after cell injection. Method of measurement: Elisa Kit.;Respiratory and lung function. Timepoint: Before Cell injection and two weeks after cell injection. Method of measurement: Physical examination , O2 saturation and CT Scan.